In contrast to previous literature [6, 8, 14], in our material comprising all breast carcinoma subtypes and up to 22-year follow-up, it was PTTG1IP-negativity that was associated with a 1.5-fold risk of breast cancer death. The gene discussed is PTTG1IP; the disease is breast cancer.